Literature DB >> 19450400

Facial acneiform rash associated with sorafenib.

Beatriz Fleta-Asín1, Sergio Vañó-Galván, Alejandro Ledo-Rodríguez, Maite Truchuelo-Díez, Pedro Jaén-Olasolo.   

Abstract

Sorafenib is an oral multikinase inhibitor that is useful in the treatment of various solid cancer. We report a patient who developed an acneiform facial eruption during treatment with this medication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450400

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  1 in total

1.  Sorafenib-associated facial acneiform eruption.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.